EXHIBIT 31.1


                           CERTIFICATION OF PRESIDENT
                PURSUANT TO THE SECURITIES EXCHANGE ACT OF 1934,
                             RULES 13A-14 AND 15D-14
                             AS ADOPTED PURSUANT TO
                  SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of  PracticeXpert,  Inc. (the "Company") on
Form 10-KSB for the period ending December 31, 2004 as filed with the Securities
and Exchange  Commission on the date hereof (the "Report"),  I, Jonathan Doctor,
President  of the Company,  certify,  pursuant to Rules 13a-14 and 15-d14 of the
Securities  Exchange  Act  of  1934,  as  adopted  pursuant  to  ss.302  of  the
Sarbanes-Oxley Act of 2002, that:

(1) I have reviewed the Report;

(2) Based upon my knowledge, the Report does not contain any untrue statement of
a material fact or omit to state a material fact  necessary in order to make the
statements made, in light of the circumstances  under which such statements were
made, not misleading;

(3) Based upon my  knowledge,  the  financial  statements,  and other  financial
information included in the Report,  fairly present in all material respects the
financial  condition and results of  operations of the Company,  as of, and for,
the periods presented in the Report;

(4) I and the other certifying officers of the Company:

         a. are responsible for establishing and maintaining disclosure controls
         and procedures for the Company;

         b. have designed such disclosure controls and procedures to ensure that
         material  information  is made  known to us,  particularly  during  the
         period in which the Report is being prepared;

         c.  have  evaluated  the  effectiveness  of  the  Company's  disclosure
         controls and procedures within 90 days of the date of the Report; and

         d. have presented in the Report our conclusions about the effectiveness
         of the  disclosure  controls  and  procedures  based  on  the  required
         evaluation.

(5) I and the other certifying officers have disclosed to the Company's auditors
and to the audit committee of the board of directors (or persons  fulfilling the
equivalent function):

         a. all significant  deficiencies in the design or operation of internal
         controls (a pre-existing term relating to internal  controls  regarding
         financial reporting) which could adversely affect the Company's ability
         to  record,  process,  summarize  and  report  financial  data and have
         identified  for the  Company's  auditors  any  material  weaknesses  in
         internal controls; and

         b. any fraud,  whether or not  material,  that  involves  management or
         other employees who have a significant  role in the Company's  internal
         controls.

(6) I and the other certifying  officers have indicated in the Report whether or
not there were significant changes in internal controls or in other factors that
could  significantly  affect internal  controls  subsequent to the date of their
evaluation,   including  any  corrective  actions  with  regard  to  significant
deficiencies and material weaknesses.


                                                 /s/Jonathan Doctor
                                                 ------------------
                                                 Jonathan Doctor, President
                                                 April 15, 2005